Published in Hum Reprod on January 01, 1995
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J Clin Invest (1998) 1.01
Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome--a preliminary proof of concept. J Ovarian Res (2014) 0.80
The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome. J Assist Reprod Genet (1998) 0.75
Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertil Steril (1993) 2.46
The Medicaid Rx model: pharmacy-based risk adjustment for public programs. Med Care (2001) 2.26
Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod (1998) 2.19
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Cervical pregnancy--a conservative stepwise approach. Hum Reprod (1999) 1.67
Laparoscopic unwinding of hyperstimulated ischaemic ovaries during the second trimester of pregnancy. Hum Reprod (1995) 1.53
Hospitalization for early bonding of the genetic mother after a surrogate pregnancy: report of two cases. Birth (2001) 1.52
Cortisol levels in human follicular fluid. Fertil Steril (1989) 1.49
Pregnancy potential of human oocytes--the effect of cryopreservation. N Engl J Med (1990) 1.43
Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril (1991) 1.43
The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril (1999) 1.42
Developmental outcome of offspring of pregestational diabetic mothers. J Pediatr Endocrinol Metab (2000) 1.42
Nicked free beta-subunit of human chorionic gonadotropin: a potential new marker for Down syndrome screening. Am J Obstet Gynecol (1996) 1.40
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors. Prenat Diagn (1999) 1.39
Early diagnosis and successful nonsurgical treatment of viable combined intrauterine and cervical pregnancy. Fertil Steril (1994) 1.35
Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril (1990) 1.35
Laparoscopic management of rudimentary horn pregnancy. Hum Reprod (1998) 1.33
In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril (1993) 1.30
Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists. Neoplasia (2001) 1.25
The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod (1990) 1.23
Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril (1994) 1.19
The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol (2009) 1.18
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum (2009) 1.18
Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility. Fertil Steril (2000) 1.18
Cytokine involvement in oocytes and early embryos. Fertil Steril (1991) 1.18
Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics (1997) 1.17
Who enrolled in a state program for the uninsured: was there adverse selection? Med Care (1993) 1.17
Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transplant (1999) 1.16
Health care utilization and cost in children with asthma and selected comorbidities. J Asthma (2001) 1.16
Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand (1999) 1.14
Failure of oocyte retrieval during in vitro fertilization: a sporadic event rather than a syndrome. Fertil Steril (1991) 1.14
Clinical, surgical and pathologic findings of adnexal torsion in pregnant and nonpregnant women. Surg Gynecol Obstet (1991) 1.14
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol (2008) 1.12
Preoperative drug dispensing as predictor of surgical site infection. Emerg Infect Dis (2001) 1.11
In vitro fertilization and cleavage of a single egg from a binovular follicle containing two individual eggs surrounded by a single zona pellucida. Fertil Steril (1987) 1.08
Muscle cells produce a low molecular weight factor with anti-cancer activity. Clin Exp Metastasis (1996) 1.08
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. Int J Clin Pharmacol Ther (2004) 1.08
Endocrinological basis of hot flushes. Obstet Gynecol Surv (1989) 1.05
Morphology and clinical outcomes of embryos after in vitro fertilization are superior to those after intracytoplasmic sperm injection. Fertil Steril (1997) 1.04
The incidence of combined intrauterine and extrauterine pregnancy after in vitro fertilization and embryo transfer. Fertil Steril (1991) 1.04
Low-back pain of pregnancy. Acta Obstet Gynecol Scand (1994) 1.01
Thrombosis of the pelvic veins associated with a large myomatous uterus. Obstet Gynecol (1998) 1.01
Acute pelvic inflammatory disease after oocyte retrieval: adverse effects on the results of implantation. Fertil Steril (1994) 1.00
Anti-tyrosinase antibodies in malignant melanoma. Cancer Immunol Immunother (1996) 1.00
Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene (2001) 0.99
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol (2008) 0.99
Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer (2003) 0.99
CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver. J Cell Physiol (2011) 0.99
Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril (1993) 0.99
Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud (1996) 0.97
Phagocytotic activity of monocytes from diabetic patients. Diabetes Care (1989) 0.97
Estimating county percentages of people without health insurance. Inquiry (1991) 0.97
A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril (1995) 0.96
Ovarian hyperstimulation syndrome: a new insight into an old enigma. J Soc Gynecol Investig (1998) 0.95
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin Exp Rheumatol (2006) 0.95
Ascertaining dementia by expert panel in epidemiologic studies of nursing home residents. Ann Epidemiol (1996) 0.95
Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet (2001) 0.94
Ovarian abscess after ovum retrieval for in-vitro fertilization. Hum Reprod (1998) 0.93
A3 adenosine receptor: pharmacology and role in disease. Handb Exp Pharmacol (2009) 0.93
Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. J Eur Acad Dermatol Venereol (2011) 0.93
Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome. Gynecol Obstet Invest (2000) 0.92
Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation. Fertil Steril (1986) 0.92
Relationship of human oocyte maturity, fertilization, and cleavage to follicular fluid prolactin and steroids. J In Vitro Fert Embryo Transf (1987) 0.92
Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod (1996) 0.92
Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril (1988) 0.91
Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol Endocrinol (1995) 0.91
Melanoma-associated hypopigmentation: where are the antibodies? Am J Clin Oncol (1996) 0.91
Satellitism of platelets to monocytes in a patient with hypogammaglobulinaemia. Scand J Haematol (1978) 0.91
Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles. Fertil Steril (1993) 0.90
The effect of smoking on the outcome of in-vitro fertilization--embryo transfer. Hum Reprod (1991) 0.90
A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum Reprod (2001) 0.90
Bilateral adnexal torsion after clomiphene citrate therapy. Hum Reprod (1991) 0.89
Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol (1996) 0.89
Failure to fertilize in vitro in couples with male factor infertility: what next? Fertil Steril (1992) 0.89
Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cell Physiol (2001) 0.88
Early sonographic detection of a 'human tail': a case report. Ultrasound Obstet Gynecol (2001) 0.88
At-risk drinking among patients making routine primary care visits. Prev Med (2000) 0.88
The value of repeat hysteroscopic evaluation in patients with failed in vitro fertilization transfer cycles. Fertil Steril (1992) 0.88
Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice. Clin Exp Metastasis (1999) 0.87
Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunother (1994) 0.87
Prenatal sonographic findings in 187 fetuses with Down syndrome. Prenat Diagn (1997) 0.86
Controlled ovarian hyperstimulation: a state of neutrophil activation. Am J Reprod Immunol (1999) 0.85
Cytokine levels in follicular fluid of polycystic ovaries in patients treated with dexamethasone. Fertil Steril (1992) 0.85
Pregnancy outcome in women with primary renal disease. Isr Med Assoc J (2000) 0.85
Psychoactive drug use by young and future physicians. J Health Soc Behav (1984) 0.85
The role of genomic imprinting in implantation. Fertil Steril (1994) 0.85
Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes. J Assist Reprod Genet (2008) 0.85
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum (1998) 0.84
The effect of betamethasone on fetal biophysical activities and Doppler velocimetry of umbilical and middle cerebral arteries. Acta Obstet Gynecol Scand (1999) 0.84
Antigens and antibodies in malignant melanoma. Tumour Biol (1994) 0.84
Controlled ovarian hyperstimulation--a state of endothelial activation. Am J Reprod Immunol (2000) 0.84
The residual ovary syndrome: a 20-year experience. Eur J Obstet Gynecol Reprod Biol (1996) 0.84
Antepartum management protocol. Timing and mode of delivery in gestational diabetes. Diabetes Care (1998) 0.84
[First trimester sonographic diagnosis of acrania]. Harefuah (1993) 0.84
The role of cervical cerclage in the management of uterine anomalies. Surg Gynecol Obstet (1991) 0.84
Intramitonchondrial crystalline inclusions in metastatic hypernephroma of the liver. Biomedicine (1974) 0.83
SEM observations on the mechanism of platelet release from megakaryocytes. Thromb Haemost (1979) 0.83
High-order multifetal gestation--management and outcome. Obstet Gynecol (1990) 0.83
The rationale for requesting a second consecutive sperm ejaculate for assisted reproductive technology. Gynecol Endocrinol (2000) 0.83